The Vioxx story: would it have ended differently in the European Union?
Thomas
W John
WJ
Law, Quinnipiac University School of Law, USA.
D003132:Commerce; D052246:Cyclooxygenase 2 Inhibitors / Q000737:chemistry; D005062:European Union; D033161:Government Regulation; D006801:Humans; D007783:Lactones / Q000737:chemistry; D019982:Organizational Case Studies; D011057:Politics; D013450:Sulfones / Q000737:chemistry
D052246:Cyclooxygenase 2 Inhibitors; D007783:Lactones; D013450:Sulfones; C116926:rofecoxib